Results 261 to 270 of about 1,087,915 (317)

AI-guided additive scoring model for differential diagnosis of primary liver cancer. [PDF]

open access: yesJHEP Rep
Salzmann RJS   +16 more
europepmc   +1 more source

Dual-targeting phytochemicals Ergosterol and Quercetagetin implicate steroid metabolism-associated pathways in lung and liver cancer models. [PDF]

open access: yesFront Pharmacol
Chen Y   +19 more
europepmc   +1 more source

[Research progress in liver cancer in 2025]. [PDF]

open access: yesZhonghua Gan Zang Bing Za Zhi
Miao TG, Nan YM.
europepmc   +1 more source

“Liver Cancer … or is it?”

Scottish Medical Journal, 1990
There has been a gradual change in the pattern of presentation of pyogenic liver abscess with an increasing incidence in the elderly. 1 At the same time an improvement in mortality with early diagnosis and treatment has been recognised.
G V, Sridharan   +2 more
openaire   +2 more sources

LIVER CANCER

Clinics in Liver Disease, 2001
The prognosis of patients with HCC remains dismal. Even in the subgroups of patients who have the most favorable characteristics and are eligible for surgical resection, the 5-year survival rate is less than 25%. For patients with more advanced disease, the median survival time is less than 1 year.
A, Aguayo, Y Z, Patt
openaire   +2 more sources

Home - About - Disclaimer - Privacy